SEC Form 4 · accession 0001078782-15-002049

VOLITIONRX LTD · VNRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Scientific Officer

Period of report

Dec 9, 2015

Accepted (ET)

Dec 18, 2015 · 2:40 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000093314

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 9, 2015	M	50,000	$3.01	A	64,290	I	Borlaug Limited
Common Stock^F1	Dec 9, 2015	F	35,834	$4.20	D	28,456	I	Borlaug Limited

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$3.01	Dec 13, 2012	M	50,000	D	Dec 13, 2012	Dec 13, 2015	Common Stock	50,000	0	I

F1These shares of Common Stock are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over these shares. However, Dr. Micallef disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2These options to purchase Common Stock were granted pursuant to the Issuer's 2011 Equity Incentive Plan dated November 17, 2011, and are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable to Borlaug Limited upon the exercise of these options. However, Dr. Micallef disclaims benefical ownership of the Options except to the extent of his pecuniary interest therein.